Ping Gao

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 01, 2026
PELO links PTEN loss to JAK1/STAT1-mediated inflammation and prostate tumor progression by stabilizing JAK1-PIK3R3 interactions.

|Sep 17, 2026
CRISPR/Cas9 screening revealed BIRC6-AS1/BIRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer.

|Aug 04, 2025
TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity.

Jing-Lan Hao, Jia-Qi He, Hang Hu

|Jan 29, 2025
VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis.

Juan Yang, Xiao Lu, Jing-Lan Hao

|Aug 29, 2024
PELO regulates erythroid differentiation through interaction with MYC to upregulate KLF10.

Jinglan Hao, Guiqin Han, Xin Liang

|Apr 19, 2022
PELO facilitates PLK1-induced the ubiquitination and degradation of Smad4 and promotes the progression of prostate cancer.

Ping Gao, Jing-Lan Hao, Qian-Wen Xie

Pageof 1

Frequent Collaborators

5 joint publications

Jinglan Hao

4 joint publications

Xiaoming Dong

2 joint publications

Kai Zhang

2 joint publications

Juan Yang